ArticleNature communications2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Nadia Mensali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ArticleNature communications2023
Nadia Mensali et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.